Clinical Oncology Alert 2013-10-01

Aromatase Inhibitor-induced Arthralgia

Aromatase inhibitor-induced arthralgia develops by week 6 of initiating aromatase inhibitor (AI) therapy, and does not appear to resolve.

Modern Radiation Therapy and ADT for High-risk Prostate Cancer Result in Improved Survival

Historically, men with high risk prostate cancer were believed to have low survival rates after definitive treatment with either surgery or radiation.

Sorafenib + TACE for Advanced HCC

In an observational cohort of 222 hepatocellular cancer patients treated in China, transarterial chemoembolization (TACE) combined with sorafenib resulted in outcomes in terms of response rates and survival that compare favorably with prior series of sorafenib used alone.

Two-step Ovarian Cancer Screening: A ‘Scissor-step’ Forward?

An 11-year prospective screening trial in 4051 menopausal women (age 50-74) demonstrates that the risk of ovarian cancer algorithm probability index.

Physician Communication and Prostate Cancer Screening

A brief web intervention improved shared decision making regarding prostate cancer screening.

Clinical Briefs in Primary Care

Evidence-based updates in primary care medicine By Louis Kuritzky, MD Supplement to Clinical Cardiology Alert, Clinical Oncology Alert, Critical Care Alert, Hospital Medicine Alert, Infectious Disease Alert, Neurology Alert, OB/GYN Clinical Alert, Primary Care Reports.

– October 1, 2013

October 1, 2013